PEAK6 Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,100
| Closed | -$2.71M | – | 3585 |
|
|
2024
Q2 | $2.71M | Sell |
13,100
-14,400
| -52% | -$3.26M | 0.01% | 1177 |
|
|
2024
Q1 | $7.45M | Buy |
27,500
+24,200
| +733% | +$5.78M | 0.02% | 638 |
|
|
2023
Q4 | $780K | Sell |
3,300
-7,500
| -69% | -$1.47M | ﹤0.01% | 2291 |
|
|
2023
Q3 | $2.12M | Buy |
+10,800
| New | +$2.22M | 0.01% | 1290 |
|
|
2023
Q2 | – | Sell |
-1,600
| Closed | -$323K | – | 4027 |
|
|
2023
Q1 | $323K | Buy |
1,600
+1,200
| +300% | +$272K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $87.2K | Sell |
400
-5,900
| -94% | -$1.29M | ﹤0.01% | 3726 |
|
|
2022
Q3 | $1.24M | Buy |
6,300
+300
| +5% | +$64.8K | 0.01% | 1986 |
|
|
2022
Q2 | $1.28M | Sell |
6,000
-3,400
| -36% | -$831K | ﹤0.01% | 2812 |
|
|
2022
Q1 | $2.67M | Sell |
9,400
-30,600
| -77% | -$9.44M | 0.01% | 1616 |
|
|
2021
Q4 | $15.1M | Sell |
40,000
-11,900
| -23% | -$4.62M | 0.03% | 530 |
|
|
2021
Q3 | $21.4M | Buy |
51,900
+22,800
| +78% | +$9.47M | 0.05% | 362 |
|
|
2021
Q2 | $10.8M | Sell |
29,100
-12,600
| -30% | -$4.21M | 0.03% | 643 |
|
|
2021
Q1 | $12.1M | Buy |
41,700
+31,300
| +301% | +$8.7M | 0.03% | 541 |
|
|
2020
Q4 | $2.6M | Sell |
10,400
-11,400
| -52% | -$2.72M | 0.01% | 1629 |
|
|
2020
Q3 | $4.94M | Sell |
21,800
-8,800
| -29% | -$1.83M | 0.01% | 960 |
|
|
2020
Q2 | $5.33M | Buy |
30,600
+28,500
| +1,357% | +$4.55M | 0.02% | 784 |
|
|
2020
Q1 | $265K | Buy |
+2,100
| New | +$315K | ﹤0.01% | 2605 |
|
|
2019
Q4 | – | Sell |
-3,000
| Closed | -$397K | – | 3487 |
|
|
2019
Q3 | $397K | Buy |
3,000
+1,900
| +173% | +$255K | ﹤0.01% | 2441 |
|
|
2019
Q2 | $156K | Sell |
1,100
-11,100
| -91% | -$1.51M | ﹤0.01% | 2980 |
|
|
2019
Q1 | $1.77M | Buy |
12,200
+10,200
| +510% | +$1.34M | 0.01% | 1390 |
|
|
2018
Q4 | $226K | Sell |
2,000
-21,300
| -91% | -$2.67M | ﹤0.01% | 2942 |
|
|
2018
Q3 | $3.13M | Buy |
+23,300
| New | +$2.88M | 0.01% | 1100 |
|
Other funds holding CRL
MG
EC